Pulmonary Delivery of Anorectic Oxyntomodulin in rats: Food Intake suppression, Reduced Body Weight Gain and Pharmacokinetics

References

• Swinburn BA Sacks G Hall KD et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet378 (9793), 804–814 (2011).
   PubMed Web of Science ®Google Scholar
• Ogden CL Carroll MD Kit BK et al. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA311 (8), 806–814 (2014).
   PubMed Web of Science ®Google Scholar
• Cawley J Meyerhoefer C . The medical care cost of obesity: an instrumental variable approach. J. Health Econ.31 (1), 219–230 (2012).
   PubMed Web of Science ®Google Scholar
• Derosa G Maffioli P . Anti-obesity drugs: a review about their effects and their safety. Expert Opin. Drug Saf.11 (3), 459–471 (2012).
   PubMed Web of Science ®Google Scholar
• Misra M . Obesity pharmacotherapy: current perspectives and future directions. Curr. Cardiol. Rev.9 (1), 33–54 (2013).
   PubMedGoogle Scholar
• Druce MR Bloom SR . Oxyntomodulin: a novel potential treatment for obesity. Treat. Endocrinol.5 (5), 265–272 (2006).
   PubMedGoogle Scholar
• Pocai A . Action and therapeutic potential of oxyntomodulin. Mol. Metab.3 (3), 241–251 (2013).
   PubMed Web of Science ®Google Scholar
• Carles-Bonnet C Martinez J Jarrousse C et al. H-Lys-Arg-Asn-Lys-Asn-Asn-OH is the minimal active structure of oxyntomodulin. Peptides17 (3), 557–561 (1996).
   PubMed Web of Science ®Google Scholar
• Wynne K Field BC Bloom SR . The mechanism of action for oxyntomodulin in the regulation of obesity. Curr. Opin. Investig. Drugs11 (10), 1151–1157 (2010).
   PubMedGoogle Scholar
• Druce MR Minnion JS Field BC et al. Investigation of structure-activity relationships of oxyntomodulin (Oxm) using Oxm analogs. Endocrinology150 (4), 1712–1722 (2009).
   PubMed Web of Science ®Google Scholar
• Halquist MS Sakagami M Karnes HT . Determination of oxyntomodulin, an anorectic polypeptide, in rat plasma using 2D-LC–MS/MS coupled with ion pair chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.903, 102–111 (2012).
   PubMed Web of Science ®Google Scholar
• Institute for Laboratory Animal Research . NationalResearch Council. Guide for the Care and Use of Laboratory Animals (Eighth Edition). The National Academies Press, Washington, DC, USA (2011). http://grants.nih.gov/grants/olaw/Guide-for-the-care-and-use-of-laboratory-animals.pdf.
   Google Scholar
• Nadkarni PP Costanzo RM Sakagami M . Pulmonary delivery of peptide YY for food intake suppression and reduced body weight gain in rats. Diabetes Obes. Metab.13 (5), 408–417 (2011).
   PubMed Web of Science ®Google Scholar
• Ionut V Burch M Youdim A et al. Gastrointestinal hormones and bariatric surgery-induced weight loss. Obesity21 (6), 1093–1103 (2013).
   PubMed Web of Science ®Google Scholar
• Hornnes PJ Kühl C Holst JJ et al. Simultaneous recording of the gastro-entero-pancreatic hormonal peptide response to food in man. Metabolism29 (8), 777–779 (1980).
   PubMed Web of Science ®Google Scholar
• Ghatei MA Uttenthal LO Christofides ND et al. Molecular forms of human enteroglucagon in tissue and plasma: plasma responses to nutrient stimuli in health and in disorders of the upper gastrointestinal tract. J. Clin. Endocrinol. Metab.57 (3), 488–495 (1983).
   PubMed Web of Science ®Google Scholar
• Peruzzo B Pastor FE Blazquez JL et al. A second look at the barriers of the medial basal hypothalamus. Exp. Brain Res.132 (1), 10–26 (2000).
   PubMed Web of Science ®Google Scholar
• Carles-Bonnet C Jarrousse C Niel H et al. Oxyntomodulin and its (19–37) and (30–37) fragments inhibit histamine-stimulated gastric acid secretion in the conscious rat. Eur. J. Pharmacol.203 (2), 245–252 (1991).
   PubMed Web of Science ®Google Scholar
• Carles-Bonnet C Jarrousse C Niel H et al. N-acetyl oxyntomodulin30–37: pharmacokinetics and activity on gastric acid secretion. Naunyn Schmiedebergs Arch. Pharmacol.345 (1), 57–63 (1992).
   PubMed Web of Science ®Google Scholar
• Dakin CL Small CJ Batterham RL et al. Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology145 (6), 2687–2695 (2004).
   PubMed Web of Science ®Google Scholar
• Liu YL Ford HE Druce MR et al. Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodents. Int. J. Obes. (Lond).34 (12), 1715–1725 (2010).
   PubMed Web of Science ®Google Scholar
• Buxton IO Benet LZ . Pharmacokinetics: the dynamics of drug absorption, distribution, metabolism, and elimination (Chapter 2). In : Goodman & Gilman's The Pharmacological Basis of Therapeutics (12th Edition). BruntonLLChabnerBAKnollmannBC ( Eds.). McGraw-Hill Professional, New York, NY, USA (2011).
   Google Scholar
• Baggio LL Huang Q Brown TJ et al. Oxyntomodulin and glucagon-like peptide-1 differently regulate murine food intake and energy expenditure. Gastroenterology127 (2), 546–558 (2004).
   PubMed Web of Science ®Google Scholar
• Bray GA . Afferent signals regulating food intake. Proc. Nutr. Soc.59 (3), 373–384 (2000).
   PubMed Web of Science ®Google Scholar
• Cohen MA Ellis SM Le Roux CW et al. Oxyntomodulin suppresses appetite and reduced food intake in humans. J. Clin. Endocrinol. Metab.88 (10), 4696–4701 (2003).
   PubMed Web of Science ®Google Scholar
• Sakagami M . Systemic delivery of biotherapeutics through the lung: opportunities and challenges for improved lung absorption. Ther. Deliv.4 (12), 1511–1525 (2013).
   PubMedGoogle Scholar
• Komada F Iwakawa S Yamamoto N et al. Intratracheal delivery of peptide and protein agents: absorption from solution and dry powder by rat lung. J. Pharm. Sci.83 (6), 863–867 (1994).
   PubMed Web of Science ®Google Scholar
• Steiner S Pfützner A Wilson BR et al. Technosphere/Insulin-proof of concept study with a new insulin formulation for pulmonary delivery. Exp. Clin. Endocrinol. Diabetes110 (1), 17–21 (2002).
   PubMed Web of Science ®Google Scholar
• Wynne K Park AJ Small CJ et al. Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes54 (8), 2390–2395 (2005).
   PubMed Web of Science ®Google Scholar
• Grant M Leone-Bay A . Peptide therapeutics: it's all in the delivery. Ther. Deliv.3 (8), 981–996 (2012).
   PubMedGoogle Scholar